Agenus (AGEN) Change in Receivables (2010 - 2026)
Agenus (AGEN) posted quarterly Change in Receivables of $4.7 million for Q1 2026, up 4480.56% year-over-year from $103284.4 in Q1 2025, and up 181.77% quarter-over-quarter from $1.7 million in Q4 2025.
Agenus (AGEN) Change in Receivables (2010 - 2026) Analysis & Trends
Agenus' Change in Receivables history runs 17 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 4480.56% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $6.6 million (up 6016.22% YoY), while the FY2025 annual figure was $1.7 million, up 106.82% from the prior year.
- Change in Receivables for Q1 2026 stood at $4.7 million, up from $1.7 million in the prior quarter.
- The five-year high for Change in Receivables was $24.8 million in Q4 2023, with the low at -$25.3 million in Q1 2024.
- The 5-year median for Change in Receivables is -$108000.0 (2025), against an average of $262000.0.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables tumbled 1862.9% in 2024, then jumped 4480.56% in 2026.
- Agenus' Change in Receivables stood at -$7.2 million in 2022, then soared by 443.97% to $24.8 million in 2023, then plunged by 98.91% to $269000.0 in 2024, then surged by 524.16% to $1.7 million in 2025, then surged by 181.77% to $4.7 million in 2026.
- Business Quant data shows AGEN's Change in Receivables at $4.7 million in Q1 2026, $1.7 million in Q4 2025, and -$183000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 8.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.16 Mn |
| Jun 30, 2026 | 8.16 Mn |
| Mar 31, 2026 | 4.73 Mn |
| Mar 31, 2026 | 4.73 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | -183,000.00 |
| Sep 30, 2025 | -183,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | -25.34 Mn |
| Mar 31, 2024 | -25.34 Mn |